Cargando…
Ebanga™: The most recent FDA-approved drug for treating Ebola
Ebolavirus (EBOV) is a virulent pathogen that causes Ebola virus disease (EVD), which is a life-threatening human condition with a fatality rate of up to 90%. Since the first outbreak in Africa in 1976, several outbreaks and epidemics of EBOV have occurred across the globe. While EVD is recognized a...
Autores principales: | Taki, Elahe, Ghanavati, Roya, Navidifar, Tahereh, Dashtbin, Shirin, Heidary, Mohsen, Moghadamnia, Marjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032372/ https://www.ncbi.nlm.nih.gov/pubmed/36969842 http://dx.doi.org/10.3389/fphar.2023.1083429 |
Ejemplares similares
-
COVID‐19 in HIV‐positive patients: A systematic review of case reports and case series
por: Heidary, Mohsen, et al.
Publicado: (2022) -
Evaluation of Brucellosis Vaccines: A Comprehensive Review
por: Heidary, Mohsen, et al.
Publicado: (2022) -
FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015) -
Possible FDA-approved drugs to treat Ebola virus infection
por: Yuan, Shu
Publicado: (2015) -
A review of FDA approved drugs and their formulations for the treatment of breast cancer
por: Chaurasia, Mohini, et al.
Publicado: (2023)